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ABSTRACT The development and homeostasis of multicellular animals requires precise coordination of
cell division and differentiation. We performed a genome-wide RNA interference screen in Caenorhabditis
elegans to reveal the components of a regulatory network that promotes developmentally programmed
cell-cycle quiescence. The 107 identified genes are predicted to constitute regulatory networks that are
conserved among higher animals because almost half of the genes are represented by clear human ortho-
logs. Using a series of mutant backgrounds to assess their genetic activities, the RNA interference clones
displaying similar properties were clustered to establish potential regulatory relationships within the net-
work. This approach uncovered four distinct genetic pathways controlling cell-cycle entry during intestinal
organogenesis. The enhanced phenotypes observed for animals carrying compound mutations attest to the
collaboration between distinct mechanisms to ensure strict developmental regulation of cell cycles. More-
over, we characterized ubc-25, a gene encoding an E2 ubiquitin-conjugating enzyme whose human ortho-
log, UBE2Q2, is deregulated in several cancers. Our genetic analyses suggested that ubc-25 acts in a linear
pathway with cul-1/Cul1, in parallel to pathways employing cki-1/p27 and lin-35/pRb to promote cell-cycle
quiescence. Further investigation of the potential regulatory mechanism demonstrated that ubc-25 activity
negatively regulates CYE-1/cyclin E protein abundance in vivo. Together, our results show that the ubc-25-
mediated pathway acts within a complex network that integrates the actions of multiple molecular mech-











The somatic development of the nematode Caenorhabditis elegans
proceeds through a highly reproducible cell lineage (Sulston and
Horvitz 1977; Kimble and Hirsh 1979; Sulston et al. 1983). The vir-
tually invariant spatiotemporal cell division pattern can be experimen-
tally exploited to detect subtle defects in the stringent control of cell
divisions that result in ectopic cell production (van den Heuvel 2005;
Kirienko et al. 2010). Several tissues are particularly well suited for
studies of developmental regulation of cell cycles. The organogenesis
of the nonessential vulva is among the most studied developmental
processes of C. elegans. The organ can be generated from six vulval
precursor cells (VPCs) that arise during the first larval stage (L1) and
immediately exit the cell cycle. This period of cell-cycle quiescence
ends in the third larval stage (L3), when the cells divide and differ-
entiate into either vulva or hypodermis (skin). The intestine and
hypodermis are also of great interest for cell-cycle studies because
of the developmentally controlled switch to specialized cell cycles
(van den Heuvel 2005). Because the loss of cell-cycle control is
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a hallmark of cancer (Hanahan and Weinberg 2011), studies of nor-
mal cell-cycle regulation during the highly coordinated development
of C. elegans provides a finely tuned model to study pathways that
potentially function in humans.
The mechanisms controlling cell-cycle progression are highly con-
served throughout eukaryotes. The orchestrated activation and inactiva-
tion of complexes consisting of cyclin-dependent kinases (CDK) and
their cyclin partners ensures the orderly progression through the phases
of the cell cycle (Nigg 1995; Morgan 1997). The regulation of cyclin/CDK
activity is accomplished through the collaboration of several distinct
mechanisms, including both transcriptional and post-transcriptional
regulation of cyclin expression, post-translational modification of CDK
and interaction with CDK inhibitors (Muller 1995; Sherr and Roberts
1999; Obaya and Sedivy 2002; Stevaux and Dyson 2002; Kitagawa et al.
2009; Mocciaro and Rape 2012). The normal regulation of the cyclin/
CDK complexes controlling the G1/S transition frequently are disrupted
in human cancers (Sherr 1996). Similarly in C. elegans, extra cell division
defects can result from dysregulation of the cyclin/CDK complexes
controlling G1/S progression (van den Heuvel 2005; Kirienko et al.
2010); thus, our studies have focused on the mechanisms regulating
the activities of G1 phase CDK complexes.
To identify the genes acting within a regulatory network that
coordinates cell-cycle progression with development, we conducted
a genome-wide, reverse genetic screen. Herein we report the 107 genes
identified by the screen whose activities were required to establish or
maintain an extended period of cell-cycle quiescence during vulva
development. Further genetic analyses of the genes suggested that at
least four pathways act in parallel to restrict cell-cycle entry.
Interestingly, inactivation of ubc-25, a gene encoding a highly con-
served E2 ubiquitin-conjugating enzyme (UBC), resulted in quies-
cence defects during vulva and intestine development. Genetic and
biochemical analyses indicated that ubc-25 acts in a linear pathway
with cul-1 to control cell-cycle quiescence and that its activity nega-
tively regulates steady-state CYE-1 abundance. Together, our studies
suggest that these newly identified genes are important cell-cycle reg-
ulators during C. elegans development and the dysfunction of their
human homologs may contribute to carcinogenesis.
MATERIALS AND METHODS
C. elegans strains and culture
C. elegans were maintained at 20 as previously described (Brenner
1974), unless stated otherwise. Animals were examined using a Zeiss
AxioImager microscope, AxioCam camera, and Axiovision software.
Image cropping and annotations were performed using Adobe Photo-
shop and ImageJ software. The following strains were used in these
studies: JK2868: qIs56[lag-2::gfp]V (Blelloch et al. 1999), KM166: cye-1
(eh10)/dpy-14(e188)I (Brodigan et al. 2003), MH1829: fzr-1(ku298)
unc-4(e120)II (Fay et al. 2002), MT6034: lin-36(n766)III (Thomas
and Horvitz 1999), MT10430: lin-35(n745)I (Lu and Horvitz 1998),
PD4667: ayIs7[hlh-8::gfp]IV (Corsi et al. 2000), RB1481: ubc-25
(ok1732)I (this study), RG733: wIs78[ajm-1::gfp + scm::gfp]IV
(Abrahante et al. 2003), SV326: rtIs14[elt-2::GFP; osm-10::HT150Q]
IV (Fukushige et al. 1998; Saito et al. 2004), SV557: cdc-14(he141)II
(Saito et al. 2004), VW22: rrf-3(pk1426)II; lin-12(n950)III; lag-2(sa37)
V (this study), and VW198: cyd-1(he112)/mIn1 II; rtIs14[elt-2::GFP;
osm-10::HT150Q]IV (Boxem and van den Heuvel 2001).
Analyses of VPC cell-cycle quiescence
The genome-wide RNA interference (RNAi) screen used the feeding
method to generate loss-of-function phenotypes (Fraser et al. 2000;
Timmons et al. 2001; Kamath et al. 2003). VW22: rrf-3(pk1426); lin-12
(n950); lag-2(sa37) triple mutant animals were used for their RNAi
hypersensitivity (Simmer et al. 2003) (Supporting Information, Figure
S1) and improved viability (Tax et al. 1994; Clayton et al. 2008)
compared with lin-12(n950) mutant animals. Primary screening of
the Ahringer RNAi feeding library (Fraser et al. 2000; Kamath et al.
2003) initiated by seeding approximately 10 L1-synchronized (Hong
et al. 1998; van den Heuvel and Kipreos 2012) VW22 animals on the
RNAi bacteria. Following 8 days of growth at 15, the F1 generation
was screened for the presence of adult animals displaying the
enhancer of lin-12(gf) multivulva (Elm) phenotype of greater than 6
pseudovulvae. The appearance of a single Elm animal was considered
a positive result. Thus, the Elm frequency was not determined during
the screen because the vast majority of positive hits consisted of
a single Elm adult amid an undetermined number of Muv (non-Elm)
adults. RNAi clones found to induce lethality or fertility defects were
reanalyzed by exposing approximately 100 synchronized L1 animals
to the feeding RNAi clone at 15 and examining the adult worms after
5 d for the Elm phenotype. A total of 1004 RNAi clones were initially
found to produce the Elm phenotype and retested. As previously de-
scribed (Saito et al. 2004), a defect of cell-cycle quiescence allows
ectopic cell divisions that produce extra VPCs. Thus, we examined
the number of VPCs at the L2-to-L3 molt using Nomarski optics to
distinguish between defects in cell fate determination and cell-cycle
quiescence. The identities of the RNAi-targeted genes were confirmed
by sequencing. 108 RNAi clones (two separate clones targeting mdt-
1.1/sop-3 were isolated) were subsequently determined to disrupt cell-
cycle quiescence.
Quantification of intestinal nuclei
The elm gene regulation of cell cycles during intestine development
was examined using standard RNAi feeding procedures and genetic
mutations when appropriate. For all experiments examining intestinal
nuclei number, visualization of intestinal nuclei was aided by rtIs14
[elt-2::GFP; osm-10::HT150Q]IV, which expresses an irrelevant neu-
ron-specific transgene, osm-10::HT150Q, in addition to an integrated
elt-2::GFP reporter. For experiments using RNAi, L4 animals were
transferred to RNAi-inducing bacteria and intestinal nuclei of L4-
to-young adult aged F1 self-progeny (n $ 10) were scored after
425 d at 20. The RNAi clone targeting unc-73 was used as the
negative control for all experiments. For assays to measure genetic
enhancement of intestinal nuclei production, significance (P-value ,
0.05) was determined by an unpaired two-tailed Student’s t-test com-
paring the double loss of activity to either single alone.
ubc-25 mutation and transgene
The strain harboring the ubc-25(ok1732) mutation, RB1481, was
obtained from the Caenorhabditis Genetics Center and outcrossed
four generations. The ok1732 1.2kb deletion was confirmed by poly-
merase chain reaction using the primers ubc-25-59ATG+Nhe, 59-
GCTAGCATGGCGTGTCTTCGAAAACTAAAAGAAGAC-39; ubc-
25-39-1, 59-CCTGATAAAACGCGAGTTTCAAAACAGCTCAC-39;
and ubc-25-39-2, 59-CATCGTCAACTTCTCCATCTCCAGC-39. The
mCherry::UBC-25 transgene contains ~1.6-kb promoter sequence up-
stream of a translational fusion between mCherry (pAA64; Audhya
et al. 2007) and UBC-25 coding sequences. The ubc-25 promoter and
coding sequences were amplified by polymerase chain reaction from
genomic DNA using the primer sets Pubc-25-59+Bam (59-GGATCCTG-
TAACCCTCATTTTTGCTCTATGTATC-39) to Pubc-25-39+Age (59-
GGTACCTCTTCTGATTTTCGCTACC-39) and ubc-25-59ATG+Nhe
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to UBC-25-39+Nhe (59-GCTAGCTTATCCTTCTGTTTTTGGAGGT-39),
respectively. The UBC-25 coding sequence was inserted in-frame in
place of the mCherry termination codon using an NheI site inserted
immediately upstream of the let-858 39 untranslated region. The pro-
moter was subsequently cloned upstream of mCherry using BamHI
and AgeI to generate the Pubc-25::mCherry::UBC-25 expression
plasmid.
4D cell lineage analyses
Wild-type and ubc-25(ok1732) embryos were imaged at 25 using
four-dimensional microscopy essentially as previously described
(Schnabel et al. 1997). Both strains contained rtIs14 for visualization
of the intestinal nuclei. Images of embryos were transformed into
four-dimensional cell lineages and analyzed using SimiBiocell software
(Simi Reality Motion Systems GmbH).
Western blot analyses
Sodium dodecyl sulfate polyacrylamide gel electrophoresis followed by
western blotting was used to measure steady-state expression of CYE-1.
For each sample, 50-100 gravid adult animals were boiled in 2X
loading buffer and proteins separated on 4–15% precast gradient
sodium dodecyl sulfate polyacrylamide gel electrophoresisgels
(BioRad). Samples were transferred to nitrocellulose membrane
and probed using anti-CYE-1 antibodies (1:2000 dilution; Brodigan
et al. 2003). Anti-a-tubulin monoclonal antibody (DM1A; Sigma-
Aldrich) was used at 1:5000 dilution. Supersignal (Thermo Scientific)
was used for developing anti-a-tubulin and anti-CYE-1 western blots.
The relative CYE-1 protein levels were quantified from scanned films
using ImageJ.
RESULTS
A genome-wide RNAi screen identified 107 cell-cycle
quiescence regulators
We previously conducted a forward genetic screen for the Elm
phenotype and identified several previously unrecognized compo-
nents of a developmental network controlling cell-cycle quiescence
in C. elegans (Saito et al. 2004; Clayton et al. 2008). The Elm screen
relies on the lin-12/Notch gain-of-function mutation to direct dif-
ferentiation of VPCs into obvious ventral protrusions called pseu-
dovulvae (Greenwald et al. 1983). Since wild-type animals produce
only six VPCs (Sulston and Horvitz 1977) and each VPC can give
rise to a single pseudovulva, lin-12(n950) animals display a maxi-
mum of six pseudovulvae (Greenwald et al. 1983). In contrast, Elm
mutant animals produce ectopic VPCs through either extra cell
divisions (Saito et al. 2004) or transformations of cell identities
(Alper and Kenyon 2001) and display greater than six pseudovul-
vae. Here we conducted an RNAi-based, genome-wide examina-
tion of the genetic network controlling VPC cell-cycle quiescence
using rrf-3(pk1426); lin-12(n950); lag-2(sa37) triple mutant animals
(Figure S1) to screen for the Elm phenotype. Each of the 16,757
RNAi clones contained within the feeding library (Fraser et al.
2000; Kamath et al. 2003) was individually tested for the ability
to induce the production of greater than six pseudovulvae (Figure
1A). The RNAi experiments found to produce the Elm extra pseu-
dovulvae phenotype were further scrutinized for ectopic VPC divi-
sions during larval development, which would indicate a defect of
cell-cycle quiescence (Hong et al. 1998). The inhibition of 107
genes by RNAi (Table S1), less than 1% of the total genes predicted
within the genome, produced the Elm phenotype as a result of
a cell-cycle quiescence defect.
The 107 genes represent putative components of a regulatory
network controlling cell-cycle quiescence during development. Nota-
bly, the identified genes included the previously characterized cell-
cycle quiescence regulators cdc-14/Cdc14 (Saito et al. 2004), cki-1/p27
(Hong et al. 1998; Feng et al. 1999; Fukuyama et al. 2003), cki-2/p27
(Buck et al. 2009), cul-1/Cul1 (Kipreos et al. 1996), and mediator
subunits mdt-1.1/sop-3/MED1 and mdt-12/dpy-22/MED12 (Clayton
et al. 2008). The identification of multiple genes known to play roles
in cell-cycle quiescence validated this screening approach. To begin
a functional evaluation of the regulatory network, we considered the
sequence conservation and tissue specificities of the 107 genes. The
genes were categorized based on the conservation of their amino acid
sequences into six general classes: (1) regulated proteolysis, (2) gene
expression, (3) metabolism, (4) signal transduction, (5) cell cycle or
(6) unknown, a group consisting of members exhibiting conservation
with either uncharacterized genes or no recognizable conservation
(Figure 1B and Table S1). We determined that 70 of the 107 genes
(65%) were represented by recognizable human orthologs (Table S1).
In fact, 47 of these genes appear on the C. elegans-human ortholog
compendium, OrthoList (Shaye and Greenwald 2011). The conserva-
tion of the genes selected by the Elm phenotype screen may indicate
an overall conservation of the mechanisms controlling cell-cycle qui-
escence between C. elegans and humans.
We next investigated whether the 107 genes identified as cell-
cycle regulators in VPCs were required for cell-cycle quiescence
during the development of an unrelated tissue, the intestine. The
entire intestine develops from a single cell that undergoes multiple
rounds of cell divisions throughout embryonic and larval de-
velopment; however, larval development incorporates unusual cell
cycles resulting in karyokinesis without cytokinesis and polyploidy
(Mcghee 2007). The exceptional development of the intestine fur-
ther enhances the detection of cell-cycle defects (Boxem and van
den Heuvel 2001). We found that the RNAi-mediated inhibition of
33 genes disrupted cell-cycle regulation as shown by the produc-
tion of extra intestinal nuclei (Figure 1C and Table S1), indicating
that these 33 genes act broadly in multiple tissues to control cell
cycles.
Figure 1 Conserved negative cell-cycle regulators were identified in
the Elm screen. (A) Schematic diagram of genome-wide RNA in-
terference (RNAi) screen. RNAi feeding clones were independently
tested for the ability to transform the progeny of lin-12(gf) multivulva
(Muv) animals into Elm animals that display greater than six pseudo-
vulvae. (B) Pie chart illustrating the distribution of the predicted func-
tions for the 107 genes identified by the Elm screen. (C) Venn diagram
of 107 genes identified by the genome-wide RNAi screen as potential
cell-cycle quiescence regulators. Thirteen genes overlap between the
33 genes also necessary for restricting cell cycles in the intestine and
the 47 genes listed on OrthoList.
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ubc-25 activity promotes cell-cycle quiescence
ubc-25 is one of 13 genes identified by the screen that both appears on
the Ortholist and acts in intestine and vulva development (Figure 1C
and Table S1). Ubiquitin-conjugating enzymes such as UBC-25 transfer
ubiquitin to a target protein substrate, usually in conjunction with an E3
ubiquitin ligase, to regulate protein activity, localization, interaction and
stability (Kipreos 2005). Accordingly, ubc-25 was examined as an ex-
ample of a potentially fundamental regulator of cell-cycle quiescence
during metazoan development. UBC-25 exhibited high amino acid se-
quence conservation with UBE2Q2, a metazoan specific UBC impli-
cated in cancer (Schulze et al. 2003; Melner et al. 2006; Maeda et al.
2009). Although we identified C. elegans ubc-25 as a regulator of VPC
cell-cycle quiescence, an analyses of VPC number at the L2-to-L3 molt
indicated that extra cell divisions were rare in the ubc-25 loss-of-
function animals (Table 1). The weak cell-cycle quiescence defect was
significantly enhanced by concurrent loss of lin-35 Rb activity. ubc-25
(RNAi) animals also displayed a variable intestine defect that frequently
lead to the observation of extra nuclei at the completion of larval de-
velopment (38.3 6 6.7, n = 20) compared with control RNAi animals
(32.26 1.3, n = 15) (Table S1). Because of the greater penetrance of the
intestinal phenotype, we focused our analyses of the role of ubc-25 in
controlling cell cycles during intestine development.
We obtained a strain harboring a predicted null mutation, ubc-25
(ok1732), that deletes the conserved ubiquitin-conjugating domain
(Figure 2A). Although the ubc-25(ok1732) animals appear superficially
normal, growth at 25 resulted in a significant reduction of self-brood
size (64.9 6 15.5 vs. 190.66 32.5 for wild type) and increase of
embryonic lethality (69.8% vs. 1.6% for wild type) (Table S2). This
decrease of fertility and fecundity is consistent with ubc-25 function-
ing in an essential process, such as cell-cycle regulation. However, the
activity of ubc-25 is not ubiquitously required for cell-cycle quiescence
because no cell-cycle defects were observed in the M, V, and somatic Z
lineages of ubc-25(ok1732) larvae (Table S3). Importantly, the ubc-25
(ok1732) mutant animals displayed extra VPCs (Table 1) and intesti-
nal nuclei (Figure 2, B and C), confirming the role of ubc-25 in
limiting cell cycles during development of these diverse tissues.
Quantification of intestinal nuclei at the beginning and end of larval
development demonstrated that the extra nuclei of ubc-25(ok1732) arise
earlier during embryogenesis (Figure 2D). Therefore, we determined the
embryonic division patterns of the E cell and its descendents that give
rise to the intestine. This cell lineage analysis revealed that the time
between consecutive mitoses was significantly decreased within ubc-25
(ok1732) embryos (Table S4). Thus, five rounds of cell divisions are
completed within roughly the same period that wild-type E lineages
complete four rounds (Figure 2E). Therefore, ubc-25(ok1732) animals
displayed a significant increase of intestinal nuclei by the completion of
embryogenesis. In contrast, during larval development the intestinal
nuclei normally undergo a series of specialized cell divisions (McGhee
2007), and the proportion of dividing intestinal nuclei were indistin-
guishable between wild-type and ubc-25(ok1732) mutant larvae (60%
and 64%, respectively). Thus, the embryonic and larval extra cell-cycle
defects during intestine and vulva development, respectively, indicated
that the primary developmental role of ubc-25 is to inhibit cell-cycle
entry and/or promote cell-cycle quiescence.
ubc-25 is widely expressed during development
To provide further confirmation of a role for ubc-25 in regulating cell
cycles and to determine its spatiotemporal expression pattern, we pro-
duced a transgene expressing a translational fusion between mCherry
and UBC-25 (Figure 3A). Although the effect on brood size or embry-
onic lethality was not examined, expression of this ubc-25(+) transgene
in ubc-25(ok1732) mutant animals restored the normal number of in-
testinal nuclei (Figure 2D), further confirming that loss of ubc-25 activ-
ity is responsible for the cell-cycle defects. The expression of ubc-25 as
indicated by the mCherry::UBC-25 chimeric protein was widespread
during embryogenesis (Figure 3, B2G), consistent with an earlier report
(Schulze et al. 2003). Interestingly, mCherry::UBC-25 appeared to lo-
calize within nuclei during early embryogenesis when cells are rapidly
dividing (Figure 3C) but progressively becomes distributed throughout
the cell later in embryogenesis when the frequency of cell cycles are
reduced (Figure 3G). The ubiquitous expression of mCherry::UBC-25
suggests that although ubc-25 activity is rate limiting in select tissues,
other processes within the network controlling cell-cycle quiescence
may conceal loss of ubc-25 activity in some cell types.
The integration of ubc-25 activity within the
regulatory network
Several genetically distinct pathways have been described that act in
parallel to control G1/S progression in the intestine (Kipreos et al. 1996;
Hong et al. 1998; Boxem and van den Heuvel 2001; Fay et al. 2002;
Kostic and Roy 2002; Saito et al. 2004; Grishok and Sharp 2005; Buck
et al. 2009; Roy et al. 2011). To place ubc-25 activity within a specific
genetic pathway, we determined whether loss of ubc-25 activity
enhanced the cell-cycle defects caused by disruptions to these known
pathways. The combination of ubc-25(ok1732) with lin-35/Rb, cki-1/
p27, cdc-14/Cdc14 or fzr-1/Cdh1 loss of activity (Figure 4, A2D, re-
spectively), or ubc-25(RNAi) with a cdc-25.1/Cdc25 gain-of-function
mutation (Figure 4E) resulted in a significant increase of intestinal nuclei
number. The enhancement of the loss-of-function phenotypes suggested
that the processes mediated by these genes function in parallel to ubc-25.
In contrast, phenotypic enhancement was not observed between ubc-25
(ok1732) and cul-1(RNAi) (Figure 4F), suggesting that these genes act
within the same pathway or complex. cul-1/Cul1 encodes a component
of an SCF (Skp1-Cul1-Fbox) ubiquitin ligase (E3 enzyme) complex
whose mammalian homologs control the abundance of cyclin E to in-
hibit cell-cycle progression (Dealy et al. 1999; Wang et al. 1999). To-
gether, these genetic interactions are consistent with ubc-25 acting in
conjunction with the SCF complex to regulate G1/S progression.
Because the cul-1-mediated pathway likely regulates the cell cycle
by targeting activities that promote cell-cycle progression, we exam-
ined cye-1/cyclin E as a potential downstream target of ubc-25. To
determine the dependence of the ubc-25(lf) extra intestinal nuclei
phenotype on cye-1 activity, we varied the cye-1(+) dosage using the
cye-1 null allele, eh10 (Brodigan et al. 2003). Heterozygous animals,
n Table 1 Enhanced cell-cycle quiescence defect of ubc-25(lf);
lin-35(lf) animals
Genotype RNAia % Elm Animalsb n
Wild type unc-73 0 65
Wild type lin-35 0 90
Wild type ubc-25 2 46
lin-35(n745) unc-73 0 27
lin-35(n745) ubc-25 23 26
ubc-25(ok1732) unc-73 6 109
ubc-25(ok1732) lin-35 22 96
RNAi, RNA interference; VPC, vulval precursor cell.
a
unc-73(RNAi) is used as the negative control.
b
The Elm cell-cycle quiescence defects were scored using the more sensitive
measure of extra VPC production by directly examining animals at the L2-to-
L3 molt.
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cye-1(eh10/+), were treated with ubc-25(RNAi), and the numbers of
intestinal nuclei were compared between the self-progeny. In wild-
type cye-1(+/+) progeny, ubc-25(RNAi) produced extra intestinal nu-
clei similar to the ubc-25(ok1732) allele. In contrast, the cye-1(eh10/+)
progeny displayed a wild-type average (Figure 5A), indicating that the
extraintestinal nuclei phenotype is dependent on cye-1(+) dosage. In-
terestingly, heterozygous cye-1(eh10/+) hermaphrodites give rise to
viable but sterile cye-1(eh10) homozygous offspring that develop into
larvae due to the persistence of maternally contributed cye-1 activity
(Fay and Han 2000; Brodigan et al. 2003). These cye-1(eh10) homo-
zygous progeny allow us to test the prediction that the function of ubc-
25 is to down regulate cye-1 activity. In fact, the loss of ubc-25 function
within the homozygous cye-1(eh10) progeny produced a weaker cell-
cycle defect presumably due to the increased stability of the maternally
contributed cye-1 activity (Figure 5A). A similar partial rescue of cell-
cycle defects was described during vulva development of cye-1; cul-1
double-mutant animals (Fay and Han 2000). Together, the genetic
data support a model wherein ubc-25 controls intestinal cell divisions
through the inhibition of cye-1 activity.
To test the hypothesis that ubc-25 inhibits cell cycles through the
control of CYE-1 protein expression, we determined the steady-state
level of CYE-1 in ubc-25-deficient animals. ubc-25(RNAi)-treated ani-
mals displayed increased CYE-1 compared with the negative control
animals (Figure 5B), confirming that ubc-25 activity negatively regu-
lates CYE-1 expression. Together, these biochemical and genetic
results demonstrate that ubc-25 activity inhibits cye-1 function and
that the cell-cycle quiescence defects of ubc-25 deficient animals are
likely due to enhanced CYE-1 activity.
To identify genes acting with ubc-25 to regulate cell cycles, we
applied a complementary biochemical approach. A yeast two-hybrid
screen using UBC-25 as bait was used to identify potential UBC-25
co-factors, regulators, or targets (Figure S2). Remarkably, the screen of
over 107 interactions isolated 30 clones that identified a single gene,
C30H7.2, encoding an ortholog of a human 44-kD endoplasmic re-
ticulum chaperone protein. Based on RNAi analyses, C30H7.2 was
found to be dispensable for cell-cycle quiescence (Figure S2). Although
a physical interaction between UBC-25 and C30H7.2 may play a sig-
nificant role in an alternative physiological process, the characterization
of this process is outside the focus of our cell-cycle regulation studies.
Genetic redundancies within the regulatory network
We noted that loss of ubc-25 activity did not result in a strong cell-
cycle phenotype, particularly when compared with the SCF compo-
nents, cul-1 and lin-23, whose loss of functions result in stronger and
more widespread hyperplasia (Kipreos et al. 1996, 2000). Thus, we
searched for evidence of parallel or overlapping functions of genes
within the regulatory network.
We first investigated potential compensatory activities between the
22 members of the C. elegans ubc family. The phenotypes resulting
from ubc gene RNAi were compared between wild-type and ubc-25
(ok1732) mutant animals to determine whether the loss of two ubc
activities produced an enhanced cell-cycle quiescence phenotype
(Table S5). The majority of ubc-targeting RNAi clones did not en-
hance the extra intestinal nuclei defect. However, inhibition of ubc-1,
ubc-17, ubc-20, or ubc-21 by RNAi resulted in significant increases of
intestinal nuclei in ubc-25(ok1732) animals but no discernible effect
was observed in wild-type animals (Figure 6A). Although the relation-
ships between these other ubc genes have not been explored further,
we can conclude that ubc-1, ubc-17, ubc-20, and ubc-21 can contribute
cell-cycle regulatory activity in the absence of ubc-25 function.
We next examined the other components of the developmental
network for potentially redundant activities. All 107 Elm screen-
Figure 2 ubc-25 is a negative
regulator of intestinal cell cycles.
(A) Schematic diagram of the
ubc-25 locus. Exons and introns
are indicated by boxes and con-
necting lines, respectively. Gray
shading indicates sequences
encoding the E2 domain. Loca-
tion of catalytic cysteine is la-
beled “C.” Region deleted by
ok1732 mutation is delineated
by labeled line. (B) Image of
wild-type L2-aged animal with in-
testinal nuclei highlighted by the
elt-2::gfp transgene within rtIs14.
(C) Image of typical ubc-25
(ok1732) age-matched animal
displaying extra intestinal nuclei.
Scale bars indicate 20 mm. (D)
Quantification of intestinal nuclei
of the indicated genotypes and
ages. ztEx223 is an extrachromo-
somal array containing the Pubc-
25::mCherry::UBC-25 expression
plasmid. The median, 25%, and
75% quartiles are shown as cen-
terline and lower and upper box
edges, respectively. The whiskers indicate the total range of values (n$ 15). (E) Comparison of representative cell lineages observed for the intestinal
E lineages of (left) wild type (wt; n = 2 embryos) and (right) ubc-25(ok1732) (n = 5 embryos) animals. The wild-type lineage is indistinguishable from
lineages previously observed in wild type (Yan et al. 2013).
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positive RNAi clones were analyzed for enhancement or suppression
of intestinal phenotypes in strains harboring the ubc-25(ok1732), cdc-
14(he141), lin-36(n766), or cyd-1(he112) mutation. Loss of lin-35 func-
tion results in transgene silencing (Hsieh et al. 1999). Therefore, we
used lin-36(n766) animals in the analyses because lin-36 acts with lin-
35 to regulate cell cycles but lin-36 is not necessary for mainte-
nance of transgene expression (Boxem and van den Heuvel 2002).
In total, 25 of the 107 RNAi clones significantly enhanced the extra
intestinal nuclei of at least one test genotype (Table S6). Specifi-
cally, the extraintestinal nuclei phenotypes resulting from ubc-25
(ok1732), lin-36(n766), and cdc-14(he141) mutations were en-
hanced by 15, 8, and 11 RNAi clones, respectively. In addition,
RNAi-mediated inhibition of three genes (B0393.6, cdc-14, or ubc-
25) partially suppressed the proliferation defects caused by the cyd-
1(he112) mutation. Importantly, ubc-25(RNAi) enhanced the lin-36
(n766) and cdc-14(he141) mutations and both cdc-14(RNAi) and
cki-1(RNAi) enhanced the ubc-25(ok1732) and lin-36(n766) muta-
tions (Table S6), corroborating our earlier results.
We used the grouping by genetic enhancement to predict
regulatory organization within the network. In addition to the
aforementioned expected results, inhibition of two genes, gmn-1 and
hda-2, enhanced the phenotypes of cdc-14(he141) and ubc-25(ok1732)
but not lin-36(n766), suggesting that these genes may act within the
lin-35-mediated process. Similarly, inhibition of nine genes (cul-1, dcp-
66, F19B10.6, F49E11.7, K09F6.9, ppk-1, Y54E10BR.3, Y71H2AM.4,
and ZK1236.9) enhanced the mutant phenotype of either lin-36(n766)
or cdc-14(he141) without effecting the ubc-25(ok1732) defect. This
approach also provides evidence for a previously unrecognized path-
way that negatively controls cell-cycle entry. We found that B0393.6,
a gene encoding a RING domain protein (Kipreos 2005), was uniquely
able to enhance intestinal nuclei in all test strains (Figure 6B). In-
tegrating the genetic enhancement results for these 107 genes provides
a framework for future studies focusing on pathway interactions in the
maintenance of cell-cycle quiescence.
Figure 3 Expression of a mCherry::ubc-25 reporter. (A) Schematic dia-
gram of the mCherry::ubc-25 transgene. Exons encoding mCherry and
UBC-25 are indicated as gray and black boxes, respectively. (B, D, F)
Nomarski and (C, E, G) epifluorescence images of ztEx223 containing
transgenic animals display the expression of the mCherry::UBC-25 fusion
protein. Embryos of approximately (B, C) 50 cells, (D, E) 100 cells, and (F,
G) bean stage are shown. Scale bars indicate 10 mm.
Figure 4 Genetic analyses indicate that ubc-25 acts with cul-1. Box and whisker plots presenting quantification of intestinal nuclei in rtIs14
animals deficient for ubc-25 activity in combination with (A) lin-35(RNAi), (B) cki-1(RNAi), (C) cdc-14(he141), (D) fzr-1(ku298), (E) cdc-25.1(rr31), and
(F) cul-1(RNAi). unc-73(RNAi) is used as a negative control. RNA interference treatment or second genetic mutation is indicated above the
horizontal line that indicates the common genetic background indicated below. Statistical significance is indicated for animals carrying the double
mutation combination compared to the greater of the two single mutations alone. n $ 19 animals examined.
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DISCUSSION
We used a genome-wide RNAi screen to uncover the genes that
constitute a developmental network controlling cell divisions in C.
elegans and uncovered 100 genes not previously known to contribute
to cell-cycle quiescence. The Elm phenotype screen proved to be
a sensitive and reliable indicator of cell-cycle defects leading to the
production of extra VPCs during development. For example, the
screen successfully identified ubc-25 despite the fact that even the null
mutation of ubc-25 rarely caused extra VPC divisions. Despite the
screen sensitivity, some genes acting within the network likely remain
undiscovered because approximately 14% of loci are not represented
within the library and some genes are refractory to RNAi inhibition
(Fraser et al. 2000; Gonczy et al. 2000; Kamath et al. 2003). Regardless,
the identification of these network components constitutes consider-
able progress toward a comprehensive understanding of the regulatory
interactions that define the network controlling cell cycles.
Elaborating a complex cell-cycle regulatory network
Of the 107 identified components of the developmental network, only
33 genes appear to be nematode specific. Thus, the majority of genes
revealed by the screen may perform conserved functions throughout
metazoans as components of the machinery coordinating cell cycles
with development. The conserved genes implicate specific processes as
crucial for cell-cycle control. For example, four genes that control gene
expression specifically through regulation of chromatin were identified
by the screen as necessary for cell-cycle quiescence: hda-2 (Shi and
Mello 1998), jhdm-1 (Maures et al. 2011), dcp-66 (Poulin et al. 2005),
and egl-27 (Herman et al. 1999; Solari et al. 1999) encode a histone
deacetylase, a histone demethylase and the p66 and MTA1 components
of the nucleosome remodeling and deacetylation (i.e., NuRD) complex,
respectively. Together with the previously described transcriptional reg-
ulators, lin-35/pRb (Lu and Horvitz 1998), mdt-1.1/MED1 and mdt-12/
MED12 (Clayton et al. 2008), these genes highlight the important
activities that can be revealed for general regulators of transcription
by examining tissue- and developmental stage-specific phenotypes. In-
triguingly, our genetic interaction data indicate functional cooperation
between lin-35/pRb, hda-2/HDAC1 and the C. elegans homolog of the
dual-function protein, gmn-1/Geminin (Luo and Kessel 2004; Yanagi
et al. 2005). In human cell lines, pRB and HDAC1 control cell cycles
through cyclin E expression (Brehm et al. 1998; Magnaghi-Jaulin et al.
1998). Similarly, Geminin acts during development to promote the
transition from a proliferative state to differentiation (Del Bene et al.
2004; Luo and Kessel 2004), possibly through a mechanism involving
chromatin acetylation (Yellajoshyula et al. 2011). As these examples
illustrate, the careful analyses of the newly identified genes may result
in crucial observations leading to a better understanding of the complex
regulatory network coordinating cell cycles with development.
Figure 5 ubc-25 is a negative regulator of cye-1. (A) Box and whisker
plot presenting the effect of ubc-25(RNAi) on intestinal nuclei number
in self-progeny of cye-1(+/2); rtIs14 hermaphrodites. For each cye-1
experimental pair, connected by horizontal lines, the RNAi treatment
of either ubc-25 or the negative control unc-73 is indicated above. n $
15 for each condition. (B) Western blot illustrating increased expres-
sion of CYE-1 upon inhibition of ubc-25 activity by RNAi. Steady-state
expression of CYE-1 is increased at least threefold (n = 3). TBA-1/
a-tubulin is used as a loading and normalization control.
Figure 6 Genetic redundancy
ensures strict control of cell-
cycle quiescence. (A) Box and
whisker plot presenting the ef-
fect of RNA interference (RNAi)-
mediated inhibition of ubc-1,
ubc-17, ubc-20, and ubc-21 on
intestinal nuclei number in wt
and ubc-25(ok1732) animals.
ubc-3(RNAi) illustrates an exam-
ple of an ubc gene that does
not display redundancy. (B)
B0393.6(RNAi) significantly en-
hanced the number of intestinal
nuclei of ubc-25(ok1732), lin-36
(n766) and cdc-14(he141) mu-
tant animals, indicating a fourth
distinct genetic pathway pro-
moting cell-cycle quiescence.
Statistical significance was de-
termined by comparing test
RNAi animals to the RNAi of
the negative control gene,
unc-73, using the two-tailed
Student t-test (P , 0.05 and
P , 0.01). n $ 15 animals ex-
amined for each condition.
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The network employs parallel circuits that converge
on regulation of CDK2 activity
Three independent pathways controlling cell-cycle quiescence have
been connected to the regulation of cyclin E/CDK2 activity in
C. elegans (Figure 7). First, lin-35/pRb inhibits transcription of cye-1
(Grishok and Sharp 2005; Kirienko and Fay 2007; Grishok et al. 2008).
Second, p27 family members inhibit the CYE-1/CDK-2 complex
(Hong et al. 1998; Boxem and van den Heuvel 2001; Fukuyama
et al. 2003; Buck et al. 2009). Third, our data demonstrate that ubc-
25 inhibits cye-1 activity, likely through CUL-1-mediated ubiquitiny-
lation and subsequent proteolysis of CYE-1 protein. Lastly, a potential
fourth process involving B0393.6 inhibits cell cycles through
a currently unexplored mechanism. These processes are interesting
in light of the recent findings that the decision between cell-cycle
entry and quiescence is determined by the activity of the cyclin E-
partner, CDK2 (Spencer et al. 2013). In the human cell lines used in
the study, the level of CDK2 activity at the end of the preceding
mitosis must meet a threshold in order for the daughter cell to enter
a new cell cycle. These results provide a molecular mechanism that is
consistent with the models previously suggested for control of cell-
cycle quiescence during the development of the Drosophila eye and
C. elegans vulva by CDK inhibitors (de Nooij et al. 1996; Clayton
et al. 2008).
The analyses presented here indicate that ubc-25 acts as a negative
regulator of steady-state CYE-1 expression, but it is not known
whether this regulation is achieved through direct ubiquitinylation
of CYE-1 by UBC-25. It is likely that UBC-25 ubiquitinylates a range
of targets to regulate a variety of processes. In fact, ubc-25 was pre-
viously recognized for roles not directly related to the cell cycle, such
as promoting a Ras-mediated cell-fate decision (Rocheleau et al. 2008)
and maintaining neuromuscular homeostasis (Schulze et al. 2003). It
would be interesting to determine whether the putative interaction
partner, C30H7.2, acts with UBC-25 in these alternative processes
Our genetic analyses provide insights into the regulatory mecha-
nisms that may explain the relatively mild loss of function phenotypes
observed when individual components are inactivated. First, other
genes within a family may provide redundant activity. For example, 22
ubc genes are encoded in the C. elegans genome and we demonstrated
that 4 genes, ubc-1, ubc-17, ubc-20, and ubc-21, could restrict intestinal
cell cycles in the absence of ubc-25 activity. However, because the
UBC-25/UBE2Q2-related proteins possess an amino-terminal exten-
sion that may confer unique regulatory or substrate specificities (Jones
et al. 2002; Melner et al. 2006), it is not known whether these four
genes acted interchangeably with ubc-25 or through a distinct compen-
satory mechanism. Second, the strict regulation of cell cycles is the
collaborative result of independent pathways. In the specific case of
intestinal cell cycles, the loss of ubc-25 activity disturbs one regulatory
mechanism that inhibits cye-1 activity, but the parallel pathways remain
intact and are collectively able to promote cell-cycle quiescence in the
majority of cases. As a consequence of the multiple pathways acting in
concert, the cell-cycle defects increase in severity upon disruption of two
or more parallel pathways. Therefore, ubc-25 illustrates the key concept
that studies of regulatory networks need to consider: when multiple
pathways cooperate to achieve robust control over a process, the loss
of a single pathway may yield a weaker than expected phenotype.
The function of human UBE2Q2, alternatively designated as
LOC92912 or UBCi, is not currently established. UBE2Q2 was
independently identified as a potential mitotic regulator (Banerjee et al.
2007), a gene expressed by the luminal epithelium of the endome-
trium at the embryo implantation site (UBCi; Melner et al. 2006), and
as a gene overexpressed in head and neck tumors (LOC92912;
Seghatoleslam et al. 2006). The observations that cancers of several
cell origins overexpress UBE2Q2 at both the transcript and protein
levels (Seghatoleslam et al. 2006; Maeda et al. 2009; Nikseresht et al.
2010) suggested a role in promoting proliferation and/or transforma-
tion. However, it is possible that the observed overexpression is actu-
ally the indirect result of a malfunctioning feedback system. For
example, expression of a cyclin E harboring mutations to confer re-
sistance to ubiquitin-mediated proteolysis in primary fibroblasts par-
adoxically resulted in accumulation of the tumor suppressors p21 and
p53 (Minella et al. 2002). Indeed, UBE2Q2 was identified on the basis
of implantation-induced expression in the luminal epithelium of the
endometrium at a time when the cells are undergoing differentiation
and apoptosis (Melner et al. 2006). Similarly, a significant increase in
the expression of a murine ortholog, UBE2Q1, was observed during
B-cell development at a stage when proliferation is abruptly terminated
(Seita et al. 2012). These observations correlating UBE2Q2 expression
with differentiation and inhibition of proliferation are consistent with
the accumulation of cells in the G0 and G1 phases upon experimental
UBE2Q2 overexpression (Maeda et al. 2009; Seghatoleslam et al.
2012). Thus, it remains to be determined whether the mammalian
UBE2Q2 acts similar to UBC-25 in physiologic cell-cycle quiescence.
During the course of these studies we often observed that the loss
of a single gene activity did not strongly disrupt cell-cycle quiescence,
whereas the combination of mutations that disrupted seemingly
disconnected processes produced stronger phenotypes. These syner-
gies illustrate the cooperation between separate activities within the
regulatory network to achieve a common outcome. We expect that the
highly reproducible developmental cell lineage of C. elegans is due in
large part to the strict management conferred by the multiple pro-
cesses working independently to coordinate cell-cycle entry with de-
velopment. Because similar safeguards likely manage cell divisions
within higher animals, further elaboration of cell-cycle quiescence
regulatory networks in C. elegans will continue to clarify the complex
mechanisms controlling cell cycles in humans.
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